Next Article in Journal
Synthesis Mechanism of Low-Voltage Praseodymium Oxide Doped Zinc Oxide Varistor Ceramics Prepared Through Modified Citrate Gel Coating
Next Article in Special Issue
Identification of Late Embryogenesis Abundant (LEA) Protein Putative Interactors Using Phage Display
Previous Article in Journal
Sol-Gel-Derived Hydroxyapatite-Carbon Nanotube/Titania Coatings on Titanium Substrates
Previous Article in Special Issue
Filamentous Bacteriophage Fd as an Antigen Delivery System in Vaccination
Int. J. Mol. Sci. 2012, 13(4), 5254-5277; doi:10.3390/ijms13045254
Review

Phage Displayed Peptides/Antibodies Recognizing Growth Factors and Their Tyrosine Kinase Receptors as Tools for Anti-Cancer Therapeutics

1
, 2
, 2
, 2
 and 2,*
Received: 9 February 2012; in revised form: 9 April 2012 / Accepted: 20 April 2012 / Published: 24 April 2012
(This article belongs to the Special Issue Phage Display)
View Full-Text   |   Download PDF [390 KB, uploaded 19 June 2014]   |   Browse Figures
Abstract: The basic idea of displaying peptides on a phage, introduced by George P. Smith in 1985, was greatly developed and improved by McCafferty and colleagues at the MRC Laboratory of Molecular Biology and, later, by Barbas and colleagues at the Scripps Research Institute. Their approach was dedicated to building a system for the production of antibodies, similar to a naïve B cell repertoire, in order to by-pass the standard hybridoma technology that requires animal immunization. Both groups merged the phage display technology with an antibody library to obtain a huge number of phage variants, each of them carrying a specific antibody ready to bind its target molecule, allowing, later on, rare phage (one in a million) to be isolated by affinity chromatography. Here, we will briefly review the basis of the technology and the therapeutic application of phage-derived bioactive molecules when addressed against key players in tumor development and progression: growth factors and their tyrosine kinase receptors.
Keywords: phage display; humanized antibody; growth factors; tyrosine kinase receptors; anticancer therapy phage display; humanized antibody; growth factors; tyrosine kinase receptors; anticancer therapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Ronca, R.; Benzoni, P.; De Luca, A.; Crescini, E.; Dell’Era, P. Phage Displayed Peptides/Antibodies Recognizing Growth Factors and Their Tyrosine Kinase Receptors as Tools for Anti-Cancer Therapeutics. Int. J. Mol. Sci. 2012, 13, 5254-5277.

AMA Style

Ronca R, Benzoni P, De Luca A, Crescini E, Dell’Era P. Phage Displayed Peptides/Antibodies Recognizing Growth Factors and Their Tyrosine Kinase Receptors as Tools for Anti-Cancer Therapeutics. International Journal of Molecular Sciences. 2012; 13(4):5254-5277.

Chicago/Turabian Style

Ronca, Roberto; Benzoni, Patrizia; De Luca, Angela; Crescini, Elisabetta; Dell’Era, Patrizia. 2012. "Phage Displayed Peptides/Antibodies Recognizing Growth Factors and Their Tyrosine Kinase Receptors as Tools for Anti-Cancer Therapeutics." Int. J. Mol. Sci. 13, no. 4: 5254-5277.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert